Early life respiratory syncytial virus disease-a preventable burden.

Cheryl Cohen, Heather J Zar
Author Information
  1. Cheryl Cohen: Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg 2000, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: cherylc@nicd.ac.za.
  2. Heather J Zar: Department of Paediatrics & Child Health and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa.

Abstract

No abstract text available.

MeSH Term

Humans
Respiratory Syncytial Virus Infections
Infant
Respiratory Syncytial Virus, Human
Infant, Newborn
Respiratory Syncytial Virus Vaccines
Cost of Illness

Chemicals

Respiratory Syncytial Virus Vaccines